Literature DB >> 19735698

Colocalization of 5-HT1F receptor and calcitonin gene-related peptide in rat vestibular nuclei.

Seong-Ki Ahn1, Roza Khalmuratova, Sea-Yuong Jeon, Jin-Pyeong Kim, Jung Je Park, Dong Gu Hur, Carey D Balaban.   

Abstract

The aim of this study was to determine whether calcitonin gene-related peptide (CGRP) colocalizes with 5-HT(1F) receptor in rat vestibular nuclei using a double immunohistochemical staining procedure. The frequent co-occurrence of migraine and balance disorders suggests a pathophysiologic link between the two. However, the mechanism of migrainous vertigo has not been elucidated, though serotonin (5-HT) and its receptors are believed to involve in the pathogenesis of migrainous vertigo. Furthermore, 5-HT(1F) receptor agonists and CGRP receptor antagonists have recently attracted attention as potential treatments for migraine, and CGRP release from trigeminal neurons has been associated with migraine. This study demonstrates the colocalization of 5-HT(1F) receptor and CGRP in the rat vestibular nuclei, which suggests that 5-HT(1F) receptor regulates the release of CGRP from vestibular nuclei. This finding indicates that 5-HT(1F) receptor agonists may ameliorate migrainous vertigo by attenuating elevated levels of CGRP release from vestibular nuclei.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19735698     DOI: 10.1016/j.neulet.2009.09.008

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

1.  Loss of α-calcitonin gene-related peptide (αCGRP) reduces the efficacy of the Vestibulo-ocular Reflex (VOR).

Authors:  Anne E Luebke; Joseph C Holt; Paivi M Jordan; Yi Shan Wong; Jillian S Caldwell; Kathleen E Cullen
Journal:  J Neurosci       Date:  2014-07-30       Impact factor: 6.167

Review 2.  New insights into pathophysiology of vestibular migraine.

Authors:  Juan M Espinosa-Sanchez; Jose A Lopez-Escamez
Journal:  Front Neurol       Date:  2015-02-06       Impact factor: 4.003

Review 3.  Central Integration of Canal and Otolith Signals is Abnormal in Vestibular Migraine.

Authors:  Susan King; Joanne Wang; Adrian J Priesol; Richard F Lewis
Journal:  Front Neurol       Date:  2014-11-10       Impact factor: 4.003

Review 4.  Meniere's Disease and Vestibular Migraine: Updates and Review of the Literature.

Authors:  Paul Tabet; Issam Saliba
Journal:  J Clin Med Res       Date:  2017-07-27

5.  Loss of α-Calcitonin Gene-Related Peptide (αCGRP) Reduces Otolith Activation Timing Dynamics and Impairs Balance.

Authors:  Sherri M Jones; Sarath Vijayakumar; Samantha A Dow; Joseph C Holt; Paivi M Jordan; Anne E Luebke
Journal:  Front Mol Neurosci       Date:  2018-08-24       Impact factor: 5.639

Review 6.  Lasmiditan mechanism of action - review of a selective 5-HT1F agonist.

Authors:  David B Clemow; Kirk W Johnson; Helen M Hochstetler; Michael H Ossipov; Ann M Hake; Andrew M Blumenfeld
Journal:  J Headache Pain       Date:  2020-06-10       Impact factor: 7.277

7.  Cilostazol induced migraine does not respond to sumatriptan in a double blind trial.

Authors:  Katrine Falkenberg; Bára Óladóttir Á Dunga; Song Guo; Messoud Ashina; Jes Olesen
Journal:  J Headache Pain       Date:  2018-02-02       Impact factor: 7.277

Review 8.  Targeted 5-HT1F Therapies for Migraine.

Authors:  Marta Vila-Pueyo
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

9.  Lasmiditan inhibits calcitonin gene-related peptide release in the rodent trigeminovascular system.

Authors:  Alejandro Labastida-Ramírez; Eloísa Rubio-Beltrán; Kristian A Haanes; Kayi Y Chan; Ingrid M Garrelds; Kirk W Johnson; Alexander H J Danser; Carlos M Villalón; Antoinette MaassenVanDenBrink
Journal:  Pain       Date:  2020-05       Impact factor: 7.926

Review 10.  Differences in the Structure and Function of the Vestibular Efferent System Among Vertebrates.

Authors:  Kathleen E Cullen; Rui-Han Wei
Journal:  Front Neurosci       Date:  2021-06-23       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.